Targeted Genetics Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Targeted Genetics Corporation.The latest application filed is for "methods for treating target joints in inflammatory arthritis using aav vectors encoding a tnf antagonist".

Company Profile

0.17.4

Targeted Genetics Corporation - Seattle WA
Targeted Genetics Corporation - N/A

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Compounds and methods to enhance rAAV transduction Grant 7,749,491 - Engelhardt , et al. July 6, 2	2010-07-06
Methods for treating target joints in inflammatory arthritis using AAV vectors encoding a TNF antagonist App 20080175845 - Anklesaria; Pervin	2008-07-24
Metabolically activated recombinant viral vectors and methods for their preparation and use App 20070087433 - Carter; Barrie J.	2007-04-19
Metabolically activated recombinant viral vectors and methods for their preparation and use Grant 7,125,717 - Carter October 24, 2	2006-10-24
Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles App 20060166318 - Lockert; Dara H. ; et al.	2006-07-27
Methods for generating high titer helper-free preparations of released recombinant AAV vectors Grant 6,995,006 - Atkinson , et al. February 7, 2	2006-02-07
Methods for generating high titer helper-free preparations of released recombinant AAV vectors Grant 6,989,264 - Atkinson , et al. January 24, 2	2006-01-24
Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors Grant 6,936,466 - Feldhaus August 30, 2	2005-08-30
Packaging cell lines for generation of high titers of recombinant AAV vectors Grant 6,924,128 - Allen August 2, 2	2005-08-02
Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes App 20050164387 - Flyer, David C. ; et al.	2005-07-28
Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles Grant 6,893,865 - Lockert , et al. May 17, 2	2005-05-17
Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors Grant 6,642,051 - Lynch , et al. November 4, 2	2003-11-04
Metabolically activated recombinant viral vectors and methods for the preparation and use Grant 6,596,535 - Carter July 22, 2	2003-07-22
Methods for generating high titer helper-free preparations of released recombinant AAV vectors Grant 6,566,118 - Atkinson , et al. May 20, 2	2003-05-20
Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders Grant 6,537,540 - Burstein , et al. March 25, 2	2003-03-25
Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors Grant 6,346,415 - Feldhaus February 12, 2	2002-02-12
Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes Grant 6,316,257 - Flyer , et al. November 13, 2	2001-11-13
Chimeric receptors for the generation of selectively-activatable TH-independent cytotoxic T cells Grant 6,083,751 - Feldhaus , et al. July 4, 2	2000-07-04
Stable lipid-comprising drug delivery complexes and methods for their production Grant 6,008,202 - Huang , et al. December 28, 1	1999-12-28
Envelope fusion vectors for use in gene delivery Grant 5,736,387 - Paul , et al. April 7, 1	1998-04-07
Generation of high titers of recombinant AAV vectors Grant 5,658,776 - Flotte , et al. August 19, 1	1997-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.